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Abstract.  The antigen defined by mAb Ki-67 is a hu- 
man nuclear protein the expression of which is strictly 
associated with cell proliferation and which is widely 
used in routine pathology as a "proliferation marker" 
to measure the growth fraction of cells in human 
tumors.  Ki-67 detects a double band with apparent 
molecular weights of 395 and 345 kD in immunoblots 
of proteins from proliferating cells. We cloned and se- 
quenced the full length eDNA, identified two differen- 
tially spliced isoforms of mRNA with open reading 
frames of 9,768  and 8,688 bp encoding for this cell 
proliferation-associated protein with calculated molec- 
ular weights of 358,761  D and 319,508 D, respectively. 
New mAbs against a bacterially expressed part and a 
synthetic polypeptide deduced from the isolated eDNA 
react with the native Ki-67 antigen,  thus providing a 
circle of evidence that we have cloned the authentic 
Ki-67 antigen eDNA. The central part of the Ki-67 
antigen eDNA contains a large 6,845-bp exon with  16 
tandemly repeated 366-bp elements, the "Ki-67 
repeats",  each including  a highly conserved new motif 
of 66 bp, the "Ki-67 motif", which encodes for the 
epitope detected by Ki-67.  Computer analysis of the 
nucleic acid and the deduced amino acid sequence of 
the Ki-67 antigen confirmed that the cDNA encodes 
for a nuclear and short-lived protein without any 
significant homology to known sequences.  Ki-67 
antigen-specific antisense oligonucleotides inhibit the 
proliferation of IM-9 cell line cells, indicating that the 
Ki-67 antigen may be an absolute requirement for 
maintaining  cell proliferation.  We conclude that the 
Ki-67 antigen defines a  new category of cell cycle- 
associated nuclear nonhistone proteins. 
C 
ELL proliferation is a biological process of fundamen- 
tal  importance  controlled  by  highly  coordinated 
mechanisms.  Complex regulatory networks mediate 
the embryonic and normal development and are responsible 
for  the  systemic  response  to  wounding  and  infection, 
whereas their dysregulation  may result in tumor formation. 
Substantial  progress in the understanding  of the mechanisms 
and the regulation  of the cell cycle has been made in recent 
years, and it has been found that numerous structures,  among 
them key regulatory molecules such as p34  ~2 or p53,  are 
cell cycle associated and undergo cell cycle-related modula- 
tions  (e.g.,  reviewed by Norbury and  Nurse,  1992,  and 
Kirschner,  1992). Many cell cycle-associated proteins occur 
in considerable amounts only transiently  in parts of the cy- 
cle, and the presence of many of them is not always strictly 
correlated with cycling cells. For example, the "proliferating 
Drs.  Schliiter  and Duchrow  contributed equally to this publication. 
cell nuclear antigen" (PCNA) ~ is also detectable in almost 
all quiescent cells adjacent to  some tumors  (Hall et al., 
1990) and, presumably due to its long biological half-life, is 
also noticed in many quiescent tumor cells of different enti- 
ties (McCormick and Hall, 1992). A possible reason for the 
occurrence of PCNA in quiescent cells is its involvement, to- 
gether with enzymes of the DNA replication  machinery,  in 
nucleotide excision repair mechanisms,  as demonstrated in 
quiescent cells after ultra-violet  irradiation  in vitro (Celis 
and Madsen,  1986;  Toschi  and  Bravo,  1988) and in vivo 
(Hall et al.,  1993). In 1983 a mAb, designated  Ki-67, was 
described which selectively reacts with the nuclei of prolifer- 
ating cells in all human tissues tested (Gerdes et al., 1983). 
Detailed cell cycle analyses have revealed that this prolifer- 
ation-associated antigen is expressed in all active parts of the 
1. Abbreviations  used in this paper: CHEF, clamped homogeneous electric 
field; PCNA, proliferating cell nuclear antigen; RACE, rapid amplification 
of cDNA ends. 
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ceils (Go) (Gerdes et al.,  1984; Schral~ et al.,  1987; Braun 
et al., 1988; Tazzari et al., 1990; Bruno and Darzynkiewicz, 
1992), indicating that the Ki-67 antigen could be used as a 
marker  for  cells  of the  "growth  fraction:  This  has  been 
confirmed  in a  tumor  xenograft model by comparing  the 
Ki-67 labeling index with the growth fraction as determined 
by the fraction of labeled mitoses method (Scott et al., 1991). 
Consequently, the determination of the growth fraction with 
the antibody Ki-67 has been widely used in histopathology 
(reviewed by Brown and Gatter,  1990, and Gerdes,  1990), 
particularly in numerous studies on the prognostic value of 
assessing cell proliferation in clinical samples of human neo- 
plasms (Gerdes et al.,  1987; Grogan et al., 1988; Hall et al., 
1988; Bouzubar et al.,  1989; Holte et al.,  1989; Nicholson 
et al., 1991; Tungekar et al., 1991; Wintzer et al., 1991; Fon- 
tana et ai., 1992; Locker et al., 1992). All these studies have 
indicated  that the Ki-67  labeling  index is an  independent 
prognosticator  for  assessing  the  clinical  outcome  of in- 
dividual patients. 
Several groups have demonstrated that the topographical 
distribution  of the  Ki-67  antigen  is  cell  cycle dependent 
(Braun et al., 1988; Guillaud et al., 1989; du Manoir et al., 
1991):  in  G1  phase  the  Ki-67  antigen  is  predominantly 
localized in the perinucleolar region, in the later phases of 
the cell cycle the antigen is also detected throughout the nu- 
clear interior, being predominantly localized in the nuclear 
matrix (Verheyen et al.,  1989a). In mitosis, the Ki-67 anti- 
gen is present  on all chromosomes  (Gerdes  et al.,  1983, 
1984) and appears in a reticulate structure surrounding the 
metaphase chromosomes (Verheyen et al.,  1989b). Because 
Ki-67  immunostalning  rapidly  decreases during  anaphase 
and  telophase,  it  has  been  concluded  that  the  antigen  is 
degraded with a biological half-life of the detectable antigen 
of less than one hour, as estimated in postmitotic cells during 
stathmokinesis  induced  by  vinblastine  (Bruno  and  Dar- 
zynkiewicz,  1992).  In contrast  to many other  cell cycle- 
associated proteins (see above), the Ki-67 antigen is consis- 
tently absent in quiescent cells and is not detectable during 
DNA repair processes (Hall et al., 1993). Thus, the presence 
of the Ki-67 antigen is strictly associated with the cell cycle 
and confined to the nucleus, suggesting an important role of 
this structure in the maintenance and/or regulation of the cell 
division cycle. 
However, functional  analysis of the antigen  detected by 
Ki-67 has been hampered by the fact that although it was first 
described a decade ago, it has not been characterized in mo- 
lecular  terms.  Using  a  very  rapid  protein  preparation 
method, we could recently demonstrate that Ki-67 detects a 
double band of polypeptides (345 and 395 kD) in immuno- 
blots of gel electrophoretically separated proteins from ly- 
sates of proliferating  cells, which was absent in lysates of 
quiescent cells (G-erdes et al., 1991). The solubilization pro- 
tocol, however, is not appropriate  for further biochemical 
purification of the protein,  as this method involves boiling 
in SDS-containing buffers. Furthermore,  our study showed 
that the antigen is highly  susceptible to proteases.  On the 
other hand, the fact that Ki-67 detects its antigen in Western 
blots indicated that it could be used for immunoscreening of 
eDNA expression libraries.  By screening a )~gtll  eDNA li- 
brary of the human cell line IM-9, we could isolate two par- 
tiai clones of the Ki-67 antigen eDNA (Gerdes et al., 1991). 
In this study we present the complete amino acid sequence 
of this exceptionally large protein,  designated "Ki-67 pro- 
tein"  in  the  following,  which  displays unusual  molecular 
properties and obviously represents a novel kind of nuclear 
protein. 
Materials and Methods 
Cell Lines and Antibodies 
The human multiple myeloma cell line IM-9 was obtained from Dr. Harald 
Stein (lnstitut fiir Pathologic, Klinikum Steglitz, Berlin, Germany). IM-9 
cell line cells were cultured under standard conditions in RPMI medium 
supplemented with antibiotics and 10%  FCS.  Peripheral blood mononu- 
clear cells were obtained from healthy donors by standard methods, mAb 
Ki-67 (IgG1) was prepared as described (Gerdes et al.,  1983). The mAbs 
MIB 5 and MIB W 21 were prepared by using either a bacterially expressed 
part of the Ki-67 antigen eDNA (Key et al.,  1993) or a 30 amino acid syn- 
thetic peptide (MIB W21) as immunogens. Somatic cell fusion, cloning, and 
screening were performed as described (Key et al.,  1993). 
Gel Electrophoresis  and Immunoblotting 
Gel electrophoresis and immunoblotting were carried out as described by 
Key et al.  (1992,  1993). 
Immunohistochemistry 
The APAAP technique was performed according to Cordell et al. (1984). 
cDNA Cloning 
Immunoscreeulng of a kgtll library of IM-9 cell line eDNA, preparation 
of )~gtll DNA, and isolation of the eDNA inserts were performed as de- 
scribed earlier (Gerdes et ai., 1991). The resulting eDNA probes were used 
to isolate overlapping eDNA clones from the kgtll library by plaque hy- 
bridization  according  to  the  guidelines  of the  manufacturer  (Clontech 
Laboratories Inc., Palo Alto, CA). The resulting clones were orientated and 
aligned with PCR, using different primer combinations and IM-9 cell line 
eDNA as template. Since the isolated eDNA clones did not contain the com- 
plete coding sequence,  "RACE"-PCR techniques (rapid amplification of 
eDNA ends) (Frohmann et al.,  1988) were appfied to obtain the 5' end and 
3' end of the eDNA. Transitions between exons and introns were determined 
by "genomic walking  ~ with inverse PCR (Triglla et al.,  1988) and intron 
spanning PCR, using genomic DNA from IM-9 cell line cells as template. 
DNA and RNA Isolation and Analysis 
Human genomic DNA, total  cellular  RNA  and poly(A)-RNA were pre- 
pared  from  IM-9  cell  line  cells  and  peripheral  blood  lymphocytes  according 
to  standard  protocols  (Sambrook  et  al.,  1989).  Northern  blot  analysis  was 
carried out as described previously (Gerdes et al.,  1991),  except that due 
to the large size of the Ki-67 antigen mRNA total RNA and poly(A)-RNA 
were electrophoretically separated with the "clamped homogeneous electric 
field" (CHEF) technique (Carle et al.,  1986). For the synthesis of eDNA, 
1 #g up to 3 ~tg total RNA were reversely transcribed with oligo(dT) or 
sequence-specific  ollgonucleotides,  using  the  Superscript  kit  (GIBCO- 
BRL, CJaithersburg, MD) according to the manufacturer's guidelines. The 
complete reverse transcriptase reactions were used for "RACE  ~ protocols 
(Frohmarm et al.,  1988) or diluted up to 500 ~i for subsequent PCR reac- 
tons. 
PCR Amplification 
About 100 tag genomic DNA or 50 ng reversely transcribed total RNA were 
subjected to 25-35 cycles of PCR, each consisting of denaturation at 940C 
for 2 rain, primer annealing at various temperatures (45-60°C) for 2 rain, 
and primer extension at 72°C for 3 rain. PCR products were electropho- 
resed through a 1% agarose gel and stained with ethidinm bromide. For se- 
quence determination, the PCR products were subcloned into the multiple 
cloning site of M13mp18/mp19. 
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Figure  /.  The  human  Ki-67 
protein  cDNA.  (,4) Cloning 
strategy.  The  overlapping 
cDNA  clones  that  were  se- 
quenced are shown above the 
scale.  The  Xgtll  clones  iso- 
lated by immunoscreening are 
designated Cla-C3, those iso- 
lated by plaque hybridization 
C4 and  C5;  all  other clones 
(C6.-C22)  were  isolated  by 
PCR techniques (Frohmann et 
al.,  1988;  Triglia  et  al., 
1988).  The fragments result- 
ing from PCR for the purpose 
of  resequencing  the  entire 
cDNA  are  designated  as 
V1-VS. (B)  Structure  of the 
human Ki-67 protein cDNAs. 
The  horizontal  lines  depict 
Ki-67 protein (LONG TYPE) 
and  Ki-67  protein  (SHORT 
TYPE) mRNA, with the direction of transcription from 5' ends (left) to 3' ends (right). Positions  of in|tons as determined by comparing 
PCR fragments from chromosomal and cDNA are indicated  by vertical  lines.  The positions of the sixteen  homologous "Ki-67 repeats" 
in the large exon 13 are demonstrated by filled boxes. The exon 7 (1,080 bp) containing mRNA of Ki-67 protein is indicated  as long type. 
In the short type mRNA Ki-67 protein exon 7 is missing.  The positions of the stop codon, the four putative polyadenylation signals,  and 
the poly(A)-tail are indicated.  The first exon is nontranslated  and contains 14 CpGs (CpG-rich island).  The start codon is located in exon 2. 
Nucleotide Sequence Determination 
DNA fragments were subcioned in M13mplS/mpl9 in both orientations. 
ssDNA  was  isolated according  to  standard protocols  (Sambrook et al., 
1989), and nucleotide sequences were determined with ALF (Automated 
Laser Fluorescent DNA Sequencer;  Pharmacia,  Uppsala,  Sweden) using 
the chain termination method (Sanger et al.,  1977) with T7 DNA polymer- 
ase and fluorescent primers according to the manufacturer's protocol (Phar- 
macia).  All oligonucleotides  were synthesized using an automated DNA 
synthesizer (model DNA SM; Beckman Instruments, Miinchen, Germany). 
DNA and amino acid sequences were aligned and analyzed using the follow- 
ing computer programs: MICROGENIE (Rel. 7.1; Beckman Instruments), 
SITESCAN (Rel.  1.2; M. Duchrow, Forschungsinstitut Borstel, Germany), 
and  HUSAR  (Rel.  3.0;  German  Cancer  Research  Center,  Heidelberg, 
Germany). 
Antisense Oligonucleotide Inhibition Assay 
1.0 ×  105 IM-9 cell line cells/150/~1  were seeded in micmtiter plates. After 
preincubation for 48 h, different concentrations of a specific synthetic oligo- 
nucleotide (5-'ATG~CCACGAGACGCCTG)  deduced  from the Ki-67 
antigen eDNA (at the position 197-218) orientated in the sense or antisense 
direction  were  added.  After  further  3  h,  cells  were  incubated  with 
[3H]thymidine (0.5 #Ci) for 5  h.  Subsequently cells were harvested, and 
the [~H]thymidine incorporation was measured. All assays were performed 
in triplicate, and the mean values were used to determine the specific inhibi- 
tion of the antisense oligonuc/eotide in comparison to the sense oligonu- 
cleofide. 
Figure 2. Verification PCR.  (A) Exon 7 spanning PCR. To verify 
the existence  of two differentially  spliced  forms of Ki-67 protein 
eDNA, three different primers (P1-P3)  were selected located within 
exon 4, 5, and 6 and combined in PCR reactions  with a reverse 
orientated primer (P4) located within  exon 8. All PCR reactions 
were separated electrophoretically (lanes  1-3), and each resulted 
in two different eDNA fragments.  Sequence analysis of these frag- 
ments revealed  the absence of exon 7 in the small PCR fragment 
(data not shown).  (B) 3'-"RACE" PCR. To demonstrate that three 
different  poly(A)-tail forms could be isolated,  we combined the 
Frohmann Adapter (/'9) (Frohmann et ul., 1988) with four different 
primers (P5-PS) 200-500-bp upstream of the four potential  poly- 
adenylation signals.  As demonstrated, the PCR reactions resulted 
in several distinct cDNA fragments (lanes 4-7). Sequence analysis 
of  three of  these fragments (lanes 4, 6, and 7) revealed the predicted 
poly(A)-tails 10-20-bp upstream of  the first, third and fourth poten- 
tial polyadenylation signals, but the poly(A)-tail of the fragment in 
lane 5 was identical  with the fragment in lane 6. 
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the eDNA encoding the human antigen of 
mAb Ki-67. The deduced amino acid se- 
quence of the Ki-67 protein eDNA is shown 
beneath  the  nucleotide  sequence.  Coor- 
dinates for the nucleotide and amino acid 
sequences are shown on the right of each 
line.  Upstream of the poly(A)-tail  of the 
eDNA there are four consensus polyadenyl- 
ation signals (AAUAAA; underlined at po- 
sitions 9,994,  10,529, and  12,468  bp and 
CAUAAA; underlined at position  11,237). 
Three signals are actively used,  since we 
found three different poly(A)-tails  immedi- 
ately downstream of each signal at positions 
10,013, 11,262, and 12,494 bp. The 24-bp- 
long  direct  repeated  boxes  (positions 
130-153,  154-177) are indicated below the 
nucleic acid sequence. Introns have been lo- 
cated at positions  107, 208, 367, 483, 550, 
596,  1676, 1852, 2165, 2284, 2456, 2612, 
9457,  and 9901; exons 7 and 13 are indi- 
cated. A potential ~ ATP/GTP binding site 
motif A  ~ (P-loop) (Saraste etal., 1990) was 
found between amino acid positions 3034- 
3041,  two  putative nuclear  targeting se- 
quences (Chelsky etal., 1989; Silver, 1991) 
were found between positions 502-505 and 
68%690,  and eight potential "bipartite nu- 
clear targeting signals  ~ (Dingwall and Las- 
key,  1991) between  amino  acid  positions 
536-550,  1516-1530,  2244-2258,  2365- 
2379,  2651-2665, 2890-2904, 2997-3011, 
and  3141-3155,  as  indicated  below  the 
amino acid sequence. Furthermore, the po- 
sitions of all 16 "Ki-67 repeats" and of the 
"Ki-67 motifs" containing the epitopo rec- 
ognized by mAb Ki-67 are indicated. CpG 
dinucleotides in the CpG-rich island (1-130 
bp)  are underlined.  These  sequence  data 
are available from the EMBL database un- 
der  the  accession  numbers X65550  and 
X65551. 
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Results 
Cloning 
To determine the primary structure of the Ki-67 protein, we 
used mAb Ki-67 to screen an expression library of IM-9 cell 
line cDNAs  constructed in ~,gtll.  From 2  x  106 plaques 
screened, 14 independent clones were isolated based on their 
reactivity  with the  antibody.  By  sequencing,  12  of these 
clones exhibited the identical 1095-bp sequence previously 
described (Gerdes etal.,  1991; Fig.  1 A, Cla-Cll), and two 
clones contained different eDNA  fragments  (Fig.  1 A,  C2 
and  C3).  Thus,  immunoscreening  yielded  three  separate 
eDNA f~agments which were subsequently used to rescreen 
the kgtl 1 IM-9 cell line eDNA library by plaque hybridiza- 
tion technique,  revealing  two additional eDNA  fragments 
(Fig. 1, C4 and C5). To verify and align these eDNA clones, 
mRNA of IM-9 cell line cells was reversely transcribed and 
amplified by PCR using primer combinations deduced from 
these  eDNA  clones  resulting  in  the  overlapping  clones 
C6-C8.  Using  5'-  and Y-"RACE"  PCR techniques  (Froh- 
mann et al.,  1988),  14 additional overlapping eDNA frag- 
ments  (Fig.  1,  C9-C22)  could be  cloned and  sequenced. 
From  a total of 22 overlapping eDNA  fragments  (Fig.  1, 
C1-C22)  we constructed the full-length eDNA. 
This arrangement of eDNA  was verified by PCR,  using 
overlapping  primer  combinations  and  by  subsequent  se- 
quencing of the PCR products (Fig.  1 A, clones 1,7-I,'8). As 
demonstrated in Fig. 2 A, these PCR products indicated the 
existence of two eDNA types differing only in the presence 
or absence of a 1,080-bp element. Chromosomal walking in 
both directions of the gene locus by inverse PCR (Triglia et 
al.,  1988) and intron spanning PCR, using genomic DNA 
from IM-9 cell line ceils as template, revealed that this gene 
consists of 14 introns and 15 exons (Fig.  1 B) and that the 
1,080-bp  element  mentioned  above  represents  one  single 
exon, i.e.,  exon 7. 
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To confirm that we have cloned the complete 5' end of the 
cDNA,  multiple independent 5'-"RACE" PCR experiments 
were performed using three different primers adjacent to the 
putative 5' end (positions 644-663,  347-365, and 118-138), 
and the resulting PCR products were cloned and sequenced. 
6 out of 9 (primer 1), 4 out of 7 (primer 2), and 2 out of 4 
(primer  3)  isolated  clones  exhibited  identical  5'  ends, 
whereas  the  remaining  clones  were  randomly  truncated 
resulting from presumably  damaged or incompletely tran- 
scribed mRNA. From these results we concluded that the 5' 
end,  as shown in Fig.  3,  represented the authentic  start of 
transcription.  Besides  the  putative  polyadenylation  signal 
within the 3' portion of the cDNAs preceding the poly(A)- 
tail shown in Fig.  3  we found two additional conservative 
putative polyadenylation sites (AAUAAA) and one site with 
a single base difference (CAUAAA). Since we could demon- 
strate three of these poly(A)-tail forms by 3'-"RACE" PCR 
(Fig. 2 B), we concluded that maximally only three polyade- 
nylation sites are biologically active.  Thus, in combination 
with the two different isoforms at least six different forms of 
Ki-67 protein mRNAs have to be postulated. 
The  complete  nucleotide  sequence  and  the  predicted 
amino acid sequence are shown in Fig. 3. The polypeptides 
deduced  from the  two open reading  frames  of 9,768  and 
8,688 bp, respectively, between the first possible start codon 
at nucleotide position  197  and the  stop codon at position 
9,965  have  calculated  molecular  weights  of 358,761  and 
319,508 D and calculated isodectric points ofpI 9.87 and pI 
9.94,  respectively. 
The central part of both isoforms of the cDNAs is encoded 
by  the  large  (6,845  bp)  exon  13,  which contains  16  con- 
catenated repeats,  the consensus sequence of which is a 366- 
bp long dement, the "Ki-67 repeat" (Fig. 4). The predicted 
amino acid sequences of these "Ki-67 repeats" exhibit a high 
degree of identical amino acids, from 43 to 62 %, with the 
consensus  sequence  shown in Fig. 4.  Within  these "Ki-67 
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Figure 4.  Comparison of the sixteen "Ki-67 repeats". All repeats belong to exon 13 of the Ki-67 protein eDNA and are direct repeats. 
Conserved amino acids shared by more than eight repeats are written as a consensus sequence in the top line, using the standard single 
letter code of the predicted amino acid sequence. Asterisks denote positions with less than eight identical amino acid residues, open spaces 
indicate gaps modified for optimal alignment. The numbers in parentheses indicate the amino acid positions. Dashes represent identical 
residues. The highly conserved sequence of the "Ki-67 motifs" and the strong PEST sequences are underlined. The highly conserved amino 
acid residues are indicated with arrows. 
repeats" there is a highly conserved 22 amino acid element 
(72  to  100%  identity with the  consensus  sequence),  the 
"10-67 motif". As all clones obtained by immunoscreening 
of the Xgtll IM-9 cell line eDNA library contained a 100% 
identical "10-67 motif  ~, it was tempting to assume that this 
repetitive 66-bp element encodes for the epitope detected by 
Ki-67. To examine this hypothesis, we cloned and expressed 
different parts of the 10-67 protein eDNA, and it turned out 
that 10-67 only detected fusion proteins including this "10-67 
motif" (see also Key et al.,  1992,  1993). 
Another feature of the central exon was the presence of 
several highly conserved amino acid residues within the six- 
teen repetitive elements (Fig. 4), e.g., a cysteine at position 
8, glutamic acids at positions 38 and 101, glycines at posi- 
tions 50 and 85, and leucine at position 103 of the consensus 
sequence. 
Northern Blot Analysis 
Earlier Northern blot analysis using the 1,095-bp fragment 
(clones Cla-Cll),  now known to be a part of exon 13, had 
shown hybridization signals with mRNA from proliferating 
cells over a range of more than 2 kb, whereas no hybridiza- 
tion was observed with mRNA of quiescent cells (Gerdes et 
al.,  1991).  In this study these findings could be confirmed 
and extended by using three isoform-specific cDNA frag- 
ments and the 1,095-bp fragment of the 10-67 protein eDNA 
as  hybridization probes.  It  was  predicted  above that  six 
different mRNA species (Fig. 5,  12.5,  11.4, 11.2,  10.2,  10, 
and 8.9 kb) should exist. As demonstrated in Fig. 5, mRNA 
prepared from proliferating cells showed two distinct bands 
with a probe specific for the 3' end of  the mRNA (Fig. 5, lane 
1), indicating the existence of two IO-67 protein mRNA iso- 
Figure 5. Northern blot anal- 
ysis.  Northern  blots  of 
poly(A)-RNA from IM-9 cell 
line  cells  (lanes  1-4)  and 
PBLs (lane 5).  Lane 1,  Hy- 
bridization with a probe spe- 
cific  for  the  3'  end  of the 
mRNA  (positions  11738- 
12302); lane 2, hybridization 
with a probe specific for exon 
7  (positions 681-1401 of the 
long eDNA type); lane 3, hy- 
bridization with a probe spe- 
cific for the mRNA without 
exon 7 (positions 505-688 of 
the short eDNA type); lanes 4 
and  5,  hybridization  with 
the 1095-bp eDNA fragment 
(clone Cla). 
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(,4) Western blot analysis  of lysates of  IM-9 cell line cells immuno- 
stained with Ki-67 (lane A), MIB 5 (lane B), and MIB W 21 (lane 
C). (B-D) Immanohistochemicai  staining  of serial frozen sections  of 
human tonsils with Ki-67 (D), MIB 5 (C),  and MIB W 21 (B). 
Bars, 100 #m. 
forms. Using an exon 7-specific eDNA probe (Fig. 5, lane 
2) and a probe specific for the "short type" eDNA (Fig. 5, 
lane 3),  the  six different mRNA species predicted above 
could be demonstrated. This was further substantiated by hy- 
bridization with the 1,095-bp eDNA fragment (clone la, i.e., 
part of exon 13) as shown in lane 4: here four strong hybrid- 
ization bands are seen, two of which presumably represent 
a double-band since four out of  the six predicted mRNA spe- 
cies  only differ by 200  bp  which  could not be  resolved 
efficiently by gel electrophoresis. It is important to note that 
none of the probes used hybridized with mRNA prepared 
from quiescent PBL (for an example of the 1,095-bp probe 
see Fig. 5, lane 5). 
Antibody Production 
To  substantiate  that  the  cDNAs  isolated  encode  for  the 
authentic Ki-67 protein, new mAbs were prepared against a 
bacterially expressed part of exon 13 and a synthetic peptide 
representing a region near the 3' end from the Ki-67 protein 
eDNA  sequence.  Fig.  6 A  shows that all new antibodies 
specifically react with the native Ki-67 protein in immuno- 
blot analysis, and Fig. 6, B-D shows the immunostaining on 
cryostat sections through human tonsils. Essentially identi- 
cai staining patterns were seen with mAb Ki-67 (Fig 6 D), 
MIB 5,  an antibody obtained using bacterially expressed 
parts of exon 13 (Fig 6 C), and MIB W 21, an antibody ob- 
tained against the synthetic peptide W 21 deduced from the 
Ki-67 protein sequence at amino acid position 3095-3125 
(Fig. 6 B). The specificity ofMIB 5 and MIB W 21 was fur- 
ther confirmed by the fact that the immunostaining of both 
antibodies could be completely inhibited by the correspond- 
ing synthetic peptides. Ki-67 and MIB 5 staining was corn- 
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from the "Ki-67 motif" of the second "Ki-67 repeat" of exon 
13 (Fig. 3, positions 3830-3889),  but remained unaffected 
by synthetic peptide W 2. Vice versa, staining with MIB W 
21 was inhibited by W 2 (the synthetic peptide used for the 
preparation of this antibody), while preincubation of MIB W 
21 with GAP had no effect. Furthermore, the epitopes recog- 
nized by the original antibody Ki-67 (see also Key et al., 
1992) and the new mAb MIB 5 are localized on the "Ki-67 
motif", whereas the epitope recognized by MIB W  21  is 
localized on a 30 amino acid region near the COOH terminus 
(see above). 
Sequence Analysis 
The eDNA-derived amino acid sequence of  the Ki-67 protein 
seems to be unique, as it did not reveal any significant ho- 
mology to any of the known sequences in databases (EMBL 
Nucleotide Sequence, Rel. 34; GenBank, Rel. 75; PIR, Rel. 
37; Swiss prot, Rel. 37). Computer analysis of the cDNAs 
and of the amino acid sequences derived thereof indicated 
that the first exon is untranslated and contains a CpG-rich 
island and two 24-bp direct repeated boxes (Fig. 3, positions 
130-153,  154-177 bp). Two potential "nuclear targeting sig- 
nals" (Chelsky et al., 1989; Silver, 1991), at amino acid posi- 
tions 502-505  and 687-690,  and eight potential "bipartite 
nuclear targeting signals" (Dingwall and Laskey, 1991), at 
amino  acid  positions  536--550,  1516-1530,  2244-2258, 
2365-2379, 2651-2665, 2890--2904,  2997-3011,  and 3141- 
3155, are well in line with the concept that both eDNA iso- 
forms encode for nuclear proteins. At the COOH terminus 
(amino acid positions 3034-3041)  we found sequence ho- 
mologies with the ATP/GTP binding site motif A ("P loop") 
(Saraste et al.,  1990).  Furthermore, the proteins seem to 
comprise more than 200 potential phosphorylation sites (143 
PKC,  89  casein kinase II,  two tyrosine kinase sites),  19 
N-myristoylation sites, and three amidation sites. 
The amino acid sequence also contains several regions 
rich in proline, glutarnic acid, serine, and threonine: desig- 
nated as PEST sites (Rogers et al., 1986).  40 weak and 10 
strong PEST sites have been determined, the latter exclu- 
sively in exon 13, flanking the highly conserved cysteine resi- 
due at position 8  of the "Ki-67  repeat" (Fig.  4).  As the 
deduced amino acid sequence is rich in proline, conforma- 
tion analysis (Chou and Fasman, 1978) predicts a high num- 
ber of turns and only a few putative or-helical regions and 
B-sheets  (not shown). 
Inhibition of Thymidine Incorporation by 
Antisense Oligonucleotides 
To examine the possible involvement of the Ki-67 protein in 
the maintenance of cell proliferation, we studied the effect 
of a synthetic deoxy-oligonucleotide complementary to the 
start of translation of the Ki-67 protein, using the corre- 
sponding sense oligonueleotide as controls.  Human IM-9 
cell line cells were treated with different concentrations of 
Ki-67 protein antisense oligonucleotides, and proliferation 
was determined by measurement of pH]thymidine uptake. 
As shown in Fig. 7,  [3H]thymidine incorporation in IM-9 
cell line cells was inhibited by antisense oligonueleotides in 
a dose-dependent manner. 
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Figure 7. Antisense oligonucleotide  inhibition assay. IM-9 cell line 
cells were incubated with various concentrations of Ki-67 protein 
mRNA-specific sense and antisense oligonucleotides, and [3t-1]~y- 
midine incorporation was measured. 
Discussion 
In the present study we provide evidences demonstrating that 
we have indeed cloned the gene that encodes the Ki-67 pro- 
tein. The clones identified by an immunoscreening strategy 
(Gerdes et al.,  1991) have been used to isolate a series of 
overlapping clones that encompass a eDNA with a unique 
highly repetitive central portion. When expressed in pro- 
karyotes, the resulting protein has been used to prepare anti- 
bodies which have been shown to have identical operational 
properties to the prototypical Ki-67 antibody in immunoblot 
and immunohistochemical assays.  Furthermore, these anti- 
bodies recognize similar epitopes, and their immunostaining 
could be specifically inhibited by synthetic peptides deduced 
from the Ki-67 protein eDNA. This defines the epitopes of 
both the prototypical mAb Ki-67 and the new antibody MIB 5 
to an identical 20 amino acid sequence, whereas the epitope 
recognized by MIB W  21 resides within a different stretch 
of 30 amino acids.  Coupled with the results obtained by 
Northern blot analysis, these data lead to the conclusion that 
the reported eDNA encodes for the Ki-67 protein. 
Analysis of the primary structure of the Ki-67  protein 
cDNA does not show any significant homologies with any 
known sequence. Indeed the structure shows a number of  un- 
usual features.  The center of the Ki-67 protein eDNA  is 
formed by a large 6,845-bp exon harboring 16 concatenated 
direct repeats (the"Ki-67 repeats") which themselves contain 
a highly conserved 66-bp element (the "Ki-67 motif") now 
known to  encode the  epitope recognized by Ki-67.  This 
repetitive and highly basic structure may have important 
functional properties and may,  as has been discussed for 
other genes containing repeats, have arisen from some an- 
cestral gene segment by internal duplication (e.g., McLean 
et al.,  1987; Wasenius et al.,  1989;  Krueger et al.,  1990). 
We identified two eDNAs which exhibited identical se- 
quences except that one exon (exon 7)  is missing in the 
shorter form. It is, therefore, likely that those two eDNAs 
represent different mRNAs formed from the same gene by 
alternative mRNA splicing. The molecular weights of the 
proteins deduced from the Ki-67 protein cDNAs correspond 
well to the sizes of the polypeptides detected as a double 
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(Gerdes et al.,  1991). Thus, we assume that each of the two 
polypeptide chains is encoded by one of these two mRNAs 
and is not a result of posttranslational modification or pro- 
teolytic  degradation.  It is  likely  that the Ki-67  protein is 
efficiently transported into the nucleus, because we found ten 
potential  "nuclear  targeting  signals;  eight  of  which  are 
bipartite, in both isoforms, which are essential for the trans- 
port of proteins into the nucleus (Chelsky et al.,  1989; Sil- 
ver,  1991;  Dingwall and Laskey,  199D. 
The  amino  acid  residues  highly  conserved  within  the 
"Ki-67  repeat;  e.g.,  cysteine,  glycine,  and glutamic  acid, 
may be involved in structure formation or functional aspects. 
The highly conserved cysteine residue at the eighth position 
is particularly conspicuous, but in view of the reducing intra- 
cellular environment (e.g.,  Ball et al.,  1992; Hwang et al., 
1992)  probably  does  not  form  intra-  and  intermolecular 
disulfide bonds.  PEST sequences (Rogers et al.,  1986) are 
presumed to represent signals for rapid proteolytic degrada- 
tion (for review see Rechsteiner,  1989, 1990). According to 
their key roles in cellular events, all known "PEST proteins" 
are strictly regulated.  The presence of multiple PEST sites 
in the Ki-67 antigen would be in line with previous observa- 
tions, indicating that this antigen is highly susceptible to pro- 
teases (Gerdes et al.,  1991) and that its biological half-life 
is very short (Bruno and Darzynkiewicz,  1992). 
Recent  studies  have  shown that the  introduction  of an- 
tisense oligonucleotides  (e.g.,  antisense c-myc or antisense 
MZF 1) in eukaryotic cells can result in a specific inhibition 
of mRNA translation (Harel-Bellan  et al.,  1988;  Bavisotto 
et al.,  1991). Using Ki-67 protein antisense oligonucleotides 
[3H]thymidine  incorporation  in IM-9  cell  line  cells  could 
be inhibited in a dose-dependent manner. This finding indi- 
cates that the expression of Ki-67 protein might be an abso- 
lute requirement for cell proliferation. In conclusion, we as- 
sume that the Ki-67 protein represents  a  new kind of cell 
cycle maintaining proteins. 
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